Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,960.50
-27.00 (-1.36%)
Feb 6, 2026, 1:09 PM CET

Genmab Revenue

Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
$3.85B
Revenue Growth
+29.57%
P/S Ratio
5.00
Revenue / Employee
$1.43M
Employees
2,681
Market Cap
122.43B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk309.06B
Coloplast27.87B
H. Lundbeck24.63B
Demant22.97B
GN Store Nord16.78B
Zealand Pharma9.16B
Bavarian Nordic6.89B
Ambu A/S6.09B
Revenue Rankings